Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaroslav A Hubacek

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Drug Metabolism and Drug Interactions|December 17, 2013
Drug metabolising enzyme polymorphisms in Middle- and Eastern-European Slavic populationsJaroslav A Hubacek
Gene|August 7, 2016
Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiologyJaroslav A Hubacek
Clinical Chemistry and Laboratory Medicine|September 24, 2005
Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variantsJaroslav A Hubacek
Molecular Diagnosis & Therapy|May 4, 2006
Role of cholesterol 7alpha-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol loweringJaroslav A Hubacek, Dagmar Bobkova
Drug Metabolism and Drug Interactions|May 12, 2011
Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular eventsJaroslav A Hubacek, Michal Vrablik
Clinical Chemistry and Laboratory Medicine|October 23, 2004
ARH missense polymorphisms and plasma cholesterol levelsJaroslav A Hubacek, Tommy Hyatt
Basic & Clinical Pharmacology & Toxicology|April 21, 2015
Response to 'CYP2E1 polymorphism and better outcome after methanol poisoning'Jaroslav A Hubacek, Sergey Zakharov
Genetics and Molecular Biology|December 16, 2014
Lack of an association between SNPs within the cholinergic receptor genes and smoking behavior in a Czech post-MONICA studyJaroslav A Hubacek, Vera Lanska, Vera Adamkova
Neuro Endocrinology Letters|November 22, 2011
Dietary intake reports fidelity--fact or fiction?Pavel Suchanek, Rudolf Poledne, Jaroslav A Hubacek
Current Atherosclerosis Reports|December 1, 2021
Statins and InflammationMartin Satny, Jaroslav A Hubacek, Michal Vrablik
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Drug Metabolism and Drug Interactions|December 17, 2013
Drug metabolising enzyme polymorphisms in Middle- and Eastern-European Slavic populationsJaroslav A Hubacek
Gene|August 7, 2016
Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiologyJaroslav A Hubacek
Clinical Chemistry and Laboratory Medicine|September 24, 2005
Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variantsJaroslav A Hubacek
Molecular Diagnosis & Therapy|May 4, 2006
Role of cholesterol 7alpha-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol loweringJaroslav A Hubacek, Dagmar Bobkova
Drug Metabolism and Drug Interactions|May 12, 2011
Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular eventsJaroslav A Hubacek, Michal Vrablik
Clinical Chemistry and Laboratory Medicine|October 23, 2004
ARH missense polymorphisms and plasma cholesterol levelsJaroslav A Hubacek, Tommy Hyatt
Basic & Clinical Pharmacology & Toxicology|April 21, 2015
Response to 'CYP2E1 polymorphism and better outcome after methanol poisoning'Jaroslav A Hubacek, Sergey Zakharov
Genetics and Molecular Biology|December 16, 2014
Lack of an association between SNPs within the cholinergic receptor genes and smoking behavior in a Czech post-MONICA studyJaroslav A Hubacek, Vera Lanska, Vera Adamkova
Neuro Endocrinology Letters|November 22, 2011
Dietary intake reports fidelity--fact or fiction?Pavel Suchanek, Rudolf Poledne, Jaroslav A Hubacek
Current Atherosclerosis Reports|December 1, 2021
Statins and InflammationMartin Satny, Jaroslav A Hubacek, Michal Vrablik
Pageof 13